Ironwood Pharmaceuticals IRWD Interest Paid, Excluding Capitalized Interest, Operating Activity
Interest Paid, Excluding Capitalized Interest, Operating Activity at other companies
Other financials
Where this comes from
Reported directly by Ironwood Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:InterestPaidNet.
The official record: Ironwood Pharmaceuticals’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ironwood Pharmaceuticals's interest paid, excluding capitalized interest, operating activity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ironwood Pharmaceuticals's interest paid, excluding capitalized interest, operating activity?
- Ironwood Pharmaceuticals (IRWD) reported interest paid, excluding capitalized interest, operating activity of $7.58M in Q4 2025.
- How has Ironwood Pharmaceuticals's interest paid, excluding capitalized interest, operating activity changed year-over-year?
- Ironwood Pharmaceuticals's interest paid, excluding capitalized interest, operating activity decreased by 6.8% year-over-year, from $8.14M to $7.58M.
- What is the long-term trend for Ironwood Pharmaceuticals's interest paid, excluding capitalized interest, operating activity?
- Over 4 years (2021 to 2025), Ironwood Pharmaceuticals's interest paid, excluding capitalized interest, operating activity has grown at a 43.2% compound annual growth rate (CAGR), from $7.22M to $30.33M.